Cyclobenzaprine Hydrochloride
NDC 43547-400, cyclobenzaprine hydrochloride, tablet, film coated, from Solco Healthcare U.S., LLC.
- Product NDC
- 43547-400
- Status
- Listed
- Labeler
- Solco Healthcare U.S., LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077797
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43547-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE10 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43547-400-01 | 43547040001 | 10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-01) |
| 43547-400-09 | 43547040009 | 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-09) |
| 43547-400-10 | 43547040010 | 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-10) |
| 43547-400-11 | 43547040011 | 1000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-11) |
| 43547-400-18 | 43547040018 | 180 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-18) |
| 43547-400-27 | 43547040027 | 270 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-27) |
| 43547-400-50 | 43547040050 | 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-50) |
| 43547-400-51 | 43547040051 | 5000 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (43547-400-51) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f558863b-ea3f-4e4b-85e9-edb2573e7151NADAC price for package 43547040010
GET /v1/drugs/nadac/43547040010NADAC price for package 43547040011
GET /v1/drugs/nadac/43547040011NADAC price for package 43547040050
GET /v1/drugs/nadac/43547040050
Use it
Look up 43547-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43547-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43547-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.